PatientsVille.com Logo

RESPIRATORY ARREST and Xanax

PatientsVille

RESPIRATORY ARREST Symptoms and Causes

Sleep apnea is a common disorder that causes your breathing to stop or get very shallow. Breathing pauses can last from a few seconds to minutes. They may occur 30 times or more an hour.

The most common type is obstructive sleep apnea. It causes your airway to collapse or become blocked during sleep. Normal breathing starts again with a snort or choking sound. People with sleep apnea often snore loudly. However, not everyone who snores has sleep apnea.

You are more at risk for sleep apnea if you are overweight, male, or have a family history or small airways. Children with enlarged tonsils or adenoids may also get it.

Doctors diagnose sleep apnea based on medical and family histories, a physical exam, and sleep study results.

When your sleep is interrupted throughout the night, you can be drowsy during the day. People with sleep apnea are at higher risk for car crashes, work-related accidents, and other medical problems. If you have it, it is important to get treatment. Lifestyle changes, mouthpieces, surgery, and breathing devices can treat sleep apnea in many people.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for RESPIRATORY ARREST

RESPIRATORY ARREST treatment research studies

Xanax clinical trials, surveys and public health registries


Find Drug Side Effect reports



Xanax Side Effects

Anxiety (349)
Insomnia (242)
Depression (220)
Feeling Abnormal (204)
Somnolence (198)
Nausea (194)
Headache (190)
Malaise (176)
Fatigue (172)
Fall (171)
Overdose (159)
Dizziness (157)
Pain (153)
Dyspnoea (145)
Suicide Attempt (143)
Diarrhoea (142)
Hypertension (137)
Confusional State (131)
Convulsion (129)
Agitation (122)
Tremor (83)
Loss Of Consciousness (75)
Sopor (74)
Intentional Overdose (73)
Amnesia (72)
Panic Attack (68)
Nervousness (64)
Back Pain (64)
Chest Pain (61)
Withdrawal Syndrome (61)
Off Label Use (60)
Suicidal Ideation (60)
Weight Increased (60)
Weight Decreased (59)
Blood Pressure Increased (58)
Vomiting (58)
Asthenia (56)
Blood Cholesterol Increased (55)
Death (53)
Road Traffic Accident (52)
Myocardial Infarction (51)
Pruritus (51)
Abdominal Pain Upper (51)
Rash (49)
Aggression (48)
Abnormal Behaviour (47)
Hypotension (46)
Decreased Appetite (46)
Oedema Peripheral (45)
Hallucination (45)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Breast pain

How long dose xanax stays in your system

I have xanax 0.25 mg im scared to take them

<b>Describe Your Tazocin Experience Here:</b>after it was administered to my farther in hospital for the first time on day he was due to be released he had a cardiac arrest with multiple organ failure and subsequently died

2 weeks after second infusion for Hodgkin's Lymphome (& RA), I had an extreme respiratory problem (BOOP). I was hospitalized twice & had high steroid does IV along with IV antiobiotics administered. After 1 year of decreasing steroi

5ml intramuscular morphine, produced respiratory depression, inability to communicate, severe drowsiness, low blood pressure but did not relieve the pain!

AGGRENOX SIDE EFFECT. PATIENT WAS PRESCRIBED PLAVIX. AGGRENOX WAS SUBSTITUTED. PATIENT SUFFERED ACUTE RESPIRATORY FAILURE AND CARDIO-RESPIRATORY ARREST. PATIENT WAS HOSPITALIZED. PATIENT DIED 3/29/09.

Anything to indicate tha Xeloda causes cardiac arrest or arrhythmia? I had cardiac arrest and the doctors can find no other reason.

Hi, I am 42 years old and I took 900mg of chasteberry for a month and a half then stopped when I became sick with the flu and ear and respiratory infection which the doctor put me on Augmentin 875-125 for 10 days. I did not have a period at

I am taking Betaloc 50 g.since last 11 years for treatment of coronary artery disaese with Hypertension.It has done nice to me without any problem. Since it is cardioseective, it has no adverse effect on respiratory system or any side effecct related

I don't know why there are no lawsuits against this company. Why is this shit on the shelves? I went into cardiac arrest. Nearly died and have suffered serious repercussions from merely treating a cold. I was hospitalized, and accused of 'robotrippin

I experienced anaphylaxis symptoms not long after one dose of z-pak. I lost my balance and fell from a short black-out, had respiratory distress and itching from hives. I had to take an antihistamine immediately and was over it in about 30 minutes.

I experienced severe nausea,convulsions,respiratory distress,abdominal pain.this was worst experience

RESPIRATORY ARREST Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation
Condition: Healthy
Interventions: Drug: alprazolam sublingual tablet commercial;   Drug: alprazolam sublingual tablet test
Outcome Measures: Alprazolam bioavailability assessed as area under the concentration-time curve (AUC) and maximum concentration (Cmax);   Alprazolam time of maximum concentration (Tmax) and half life;   Adverse events, clinical laboratory tests, vital signs
2 Recruiting Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T
Condition: Psychotropic Drugs Effects
Interventions: Drug: Zolpidem;   Drug: Alprazolam;   Drug: Caffeine;   Other: Placebo
Outcome Measures: Change in blood oxygen level-dependent (BOLD) signal as measured with fMRI;   Change in subjective drug effects as measured by self-report questionnaires
3 Unknown  Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
Condition: Generalized Anxiety Disorder
Interventions: Drug: Alprazolam (Xanax);   Drug: Placebo
Outcome Measures: To evaluate the effect of an anxiolytic drug versus placebo on brain activity at rest and during emotional stimuli using fMRI.;   To evaluate the effects of an anxiolytic drug versus placebo on eye blink startle response at rest and during emotional stimuli (anxiety potentiated startle, APS) as well as on clinical scales.;   To correlate the fMRI measurements with the clinical/behavioral measurements of efficacy.
4 Unknown  Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
Condition: Anxiety Disorder
Interventions: Drug: buspirone+alprazolam;   Drug: alprazolam;   Other: healthy controls
Outcome Measures: change from baseline in depressive symptom scores at 8 weeks;   change from baseline in depressive symptom scores at 4 weeks;   change from baseline in depressive symptom scores at 1 week;   change from baseline in anxiety symptom scores at 8 weeks;   change from baseline in anxiety symptom scores at 4 weeks;   change from baseline in anxiety symptom scores at 1 week;   changes from baseline in brain structure, function, and biochemical metabolism, analyzed using the computational approach;   number of participants with adverse events
5 Recruiting Gabapentin Treatment of Benzodiazepine Dependence
Condition: Benzodiazepine Dependence
Interventions: Drug: gabapentin;   Drug: Placebo
Outcome Measure: Abstinence from Benzodiazepine use
6 Recruiting Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Condition: Anxiety Disorders
Intervention:
Outcome Measure:
7 Recruiting Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions
Conditions: Anesthesia; Reaction;   Adverse Effect of Other General Anesthetics;   Adverse Anesthesia Outcome;   Acute Kidney Injury
Interventions: Procedure: epidural catheter insertion;   Procedure: robot assisted laparoscopic urogenital surgery
Outcome Measures: acute kidney injury;   postoperative outcome
8 Recruiting Effects of Hallucinogens and Other Drugs on Mood and Performance
Condition: Healthy
Intervention: Drug: Hallucinogens and psychoactive substances
Outcome Measures: Rating of "Drug Liking" on the End of Day Questionnaire;   Hallucinogen Rating Scale